EMERYVILLE, Calif., Feb. 7, 2012 (GLOBE NEWSWIRE) — NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide (R) compounds for the topical treatment and …
Henan Kangtai Pharmaceutical Co., Ltd.
Norfloxacin|Norfloxacin HCL|Norfloxacin Nicotinate|Norfloxacin Lactate|Pefloxacin Mesylate|Mitomycin C|